Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Adrenal enzyme deficiency].

M G Forest1

  • 1INSERM-U 329, Hôpital Debrousse 69322 Lyon.

La Revue Du Praticien
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Congenital adrenal hyperplasia (CAH) is often caused by 21-hydroxylase deficiency. Genetic and hormonal tests can now predict clinical forms, enabling prenatal diagnosis and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling the Mechanisms by Which Coexisting Biomolecular RNA-Protein Condensates Form.

Bulletin of mathematical biology·2020
Same author

A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse.

Journal of controlled release : official journal of the Controlled Release Society·2018
Same author

Nonlinear signatures of entangled polymer solutions in active microbead rheology.

Journal of rheology·2014
Same author

[A new possible phenotype of carbimazole embryopathy: A case report].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2010
Same author

Prenatal treatment of congenital adrenal hyperplasia.

Trends in endocrinology and metabolism: TEM·2008
Same author

21-Hydroxylase deficiency: an exemplary model of the contribution of molecular biology in the understanding and management of the disease.

Annales d'endocrinologie·2005
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Endocrinology
  • Genetics
  • Pediatrics

Background:

  • Congenital adrenal hyperplasia (CAH) is a group of genetic disorders affecting the adrenal glands.
  • Mutations in the CYP21 gene, leading to 21-hydroxylase deficiency, account for 95% of CAH cases.

Purpose of the Study:

  • To summarize the clinical presentations, diagnostic methods, and genetic basis of 21-hydroxylase deficiency.
  • To highlight the advancements in prenatal diagnosis and treatment of CAH.

Main Methods:

  • Review of clinical presentations (classical and non-classical).
  • Hormonal assays: plasma 17 OH progesterone and ACTH stimulation test.
  • Molecular biology techniques for CYP21 gene mutation identification.

Main Results:

Related Experiment Videos

  • Classical CAH presents with adrenal insufficiency and sexual ambiguity in females.
  • Non-classical CAH manifests later with hyperandrogenism.
  • Genetic mutations in CYP21 are well-characterized and easily identifiable.
  • Combined hormonal and molecular testing allows for accurate prediction of clinical forms.

Conclusions:

  • Prenatal diagnosis of CAH is feasible through combined hormonal and molecular testing.
  • Prenatal treatment can be considered for predicted severe forms of CAH.